Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
11 hedge funds and large institutions have $94.9K invested in Petros Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
10% more funds holding
Funds holding: 10 → 11 (+1)
0% less capital invested
Capital invested by funds: $94.9K → $94.9K (-$1)
0% more ownership
Funds ownership: 0.12% → 0.12% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$45.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$34.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.8K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$32 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$305 |
| 2 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
-$178 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$80 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$21 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$18 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $32K | +$45.1K | +2,810 | New |
|
|
TSS
2
Two Sigma Securities
New York
| $24.6K | +$34.6K | +2,155 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $14.6K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $13.9K | +$12.8K | +795 | +189% |
|
5
BlackRock
New York
| $7.55K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1.5K | -$80 | -5 | -4% |
|
|
EL
7
EMFO LLC
Weston,
Florida
| $458 | – | – | – |
|
8
National Bank of Canada
Montreal,
Quebec, Canada
| $136 | – | – | – |
|
9
Group One Trading
Chicago,
Illinois
| $36 | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| $25 | +$32 | +2 | New |
|
|
11
Morgan Stanley
New York
| $9 | -$305 | -19 | -95% |
|
12
1832 Asset Management
Toronto,
Ontario, Canada
| $5 | – | – | – |
|
|
NFSG
13
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$178 | -5 | Closed |
|
|
14
Osaic Holdings
Scottsdale,
Arizona
| – | -$21 | -1 | Closed |
|
|
15
Wells Fargo
San Francisco,
California
| – | -$18 | – | – |
|
PTPI Hedge Fund Activity: Q2 2024 in Review
11 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q2 2024, worth a combined $94.9K — down 0% from $94.9K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PTPI positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $45.1K. The largest seller was Morgan Stanley, cutting an estimated $305.
- 11 institutional investors held Petros Pharmaceuticals (PTPI) as of Q2 2024, up from 10 in Q1 2024.
- Funds reported $94.9K of Petros Pharmaceuticals stock for Q2 2024, down 0% quarter-over-quarter.
- 3 funds opened new Petros Pharmaceuticals positions in Q2 2024 and 2 closed out, a net change of +1 holder.
- The largest Petros Pharmaceuticals buyer in Q2 2024 was Virtu Financial, an estimated $45.1K added.
- The largest Petros Pharmaceuticals seller in Q2 2024 was Morgan Stanley, an estimated $305 sold.
Based on aggregated 13F filings for Q2 2024.